Canada Breast Cancer Therapeutics Market Trends, Growth, Analysis and Forecast to 2025

Canada breast cancer therapeutics market is estimated to grow significantly at a CAGR of around 8.8% during the forecast period. The factors that enable the growth of the market include the prevalence of breast cancer and the initiative by the government and private organizations. Breast cancer is the second leading cause of mortality in Canada. The incidence rate of breast cancer in Canada slightly increases with the increase in years. According to the Canadian Cancer Society about 26,300 women diagnosed with breast cancer in 2017. This accounts for 25% of all new cancer cases in women. The most common age for breast cancer in Canadian women is 50-70. The mortality rates from breast cancer are decreased due to early diagnosis and treatment options. According to the Canadian Cancer society, the mortality rate per 100,000 was 23.2 in 2017.

Get Sample Copy of Canada Breast Cancer Therapeutics Market at: https://www.omrglobal.com/request-sample/canada-breast-cancer-therapeutics-market

The companies which are contributing to the growth of the Canada breast cancer therapeutics market include AbbVie Inc., Amgen Inc., Astellas Pharma Inc., Bristol-Myers Squibb Co., Eli Lilly and Co., Halozyme, Inc., Johnson & Johnson Services Inc., Merck & Co., Inc., Pfizer Inc., and others.

Canada breast cancer therapeutics market is segmented on the basis of therapy. The therapy segment is further classified into chemotherapy, hormone therapy, targeted therapy, radiation therapy and others (surgery). Among all therapies, the chemotherapy market held the largest market share in the Canada breast cancer therapeutics market. Chemotherapy is most used when cancer in the lymph nodes and irrespective of tumor size or menopausal status. Along with that it is used for the treatment of breast cancer in premenopausal women and referred for those women who diagnosed with early stage breast cancer for hormone receptor negative and HER2 positive cancer. The types of chemotherapy include adjuvant chemotherapy and neoadjuvant chemotherapy.

For More Information, get A full report of Canada Breast Cancer Therapeutics Market is available at: https://www.omrglobal.com/industry-reports/canada-breast-cancer-therapeutics-market

The adjuvant chemotherapy is used to destroy cancer cells that have been spread and not seen by the imaging tests. This method helps in reducing the cancer cells that form a new tumor in the other place of the body. Adjuvant chemotherapy reduces the risk of breast cancer coming back. Neoadjuvant chemotherapy can be used to reduce the size of the tumor, so it can be removed with less widespread surgery. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

Market Segmentation

Breast Cancer Therapeutics Market by Therapy

o Chemotherapy
o Hormone Therapy
o Targeted Therapy
o Radiation Therapy
o Others (Surgery)

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/canada-breast-cancer-therapeutics-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.